Scancell Share Discussion Threads

[tosh123] 04/2/2019 12:08

whats that got to do with anything ?
That was in Oct 2016 and a " newly designed " devise, NOT 2013 ( 3 years earlier ), and furthermore, it was seeking "US" approval for the first time..Totally different set of circumstances, at a totally different time.

Just slither away...

No picking up or dusting off required, your counter " evidence " holds no water what so ever.
Just admit it... you're WRONG yet again... £8 ... no risk here... what an oaf.

I think that i speak for most people here when i tell you to "jog on" back to the other place.

[oldnotwise] 04/2/2019 12:04

Oh for heaven's sake.... I see there's evidence of bits of fatberg apprearing on this BB. it won't be long before we'll have trouble getting through the mass of congealed and cloying effluent as it clogs and stifles the discussions.......
Shame, it was all going rather well.
ATB

[gazza] 04/2/2019 12:04

who's interested in 2 year old history?

[inanaco] 04/2/2019 12:02

Just pick yourself up Tosh ... Dust yourself down .. and join Gazza in the Space Cadet Program ..

You are overqualified ...

[inanaco] 04/2/2019 11:47

Big Cheque book ... Inovio

oh look ... Questions raised by the FDA on electroporation device

PLYMOUTH MEETING, Pa., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its proposed phase III clinical program for VGX-3100. A clinical hold is a notification issued by the FDA to a trial sponsor to delay a proposed clinical trial or suspend an ongoing clinical trial. This study has not yet been initiated and has not enrolled or dosed subjects. Additionally, the hold does not pertain to any of Inovio’s other ongoing clinical studies.

Inovio anticipates receiving a formal letter with complete information from the FDA within 30 days. In its initial communication, the FDA has requested additional data to support the shelf-life of the newly designed and manufactured disposable parts of the CELLECTRA® 5PSP immunotherapy delivery device. Inovio is working diligently with the FDA to address its concerns and anticipates that the requested data will be available before the end of this year. Inovio estimates that the start of the phase III clinical program will be delayed until the first half of 2017 pending resolution of the FDA’s requests.

[tosh123] 04/2/2019 11:44

My reply to your reply = YES

[inanaco] 04/2/2019 11:30

tosh Posts

"""A large multi national Pharma would not have experienced or let the same delays to have occurred."""

my reply .. really !!

[tosh123] 04/2/2019 11:25

as usual , you talk total RUBBISH....
This was back in 2013.
A large multi national Pharma would not have experienced or let the same delays to have occurred.

Slither off back to the other place, you're not welcome here.
Your lies have been exposed YET AGAIN.

[inanaco] 04/2/2019 11:24

Best not to remind Lozan of the Burning of France or Corbyn's Venezuela

might open up a few bed sores

[the real lozan] 04/2/2019 11:20

As *WE ALL* CAN see -
*WE ALL* CAN rely on the 'windbag walkers' to verify my point in my 19275 post.
P S
Sorry for the 'spelling mistake'

[torquayfan] 04/2/2019 11:15

Eureka ! Inan - when (if) the party comes, we can have a whip round and enlist Gazza on a Virgin Galactic flight so he can take a closer look ?? P7 might like to go too ?

I'm off now. ATB

[inanaco] 04/2/2019 11:02

Tosh ...

The license of SCIB1 was still dependent on maybe an upfront plus stage payments etc

so we would still be waiting for IChor new Gun to be approved, indeed SCIB1 remanufactured ...

so you would be now moaning about not getting stage payment !!

[the real lozan] 04/2/2019 11:02

Tosh et al -
IF, one was in a position of 'responsibilty' and 'in charge' of HUGE sums of monies to invest...say, a position within a BIG PHARMA...Would it not occur to one to 'investigate' deeper into the background of the 'proposed investment'. ???
One might easily take it upon one'self to check-up on forums/BBs, to gain an 'insight' as to what existing shareholders of said 'propsed investment' were saying/thinking.
Had ANYONE 'in a position of 'responsibilty' and 'in charge' of HUGE sums of monies to invest...say, a position within a BIG PHARMA..' looked-in on the M F F F = This might explain WHY any 'proposed investments' went ELSEWHERE.

[inanaco] 04/2/2019 10:58

Tf ... Scancell never intended to sell at Phase 1 ....Panama is wrong

[tosh123] 04/2/2019 10:57

Gazza.,
our resident village idiot is still on the " no one understands " soapbox.

Of course the market understands, they're all looking to achieve the same thing whether that be via internal scientific development, or buying other peoples IP.

As for being thankful that no sale took place, i just find that statement totally bonkers is every respect.
Firstly, and most importantly, one platform or another would have been far more progressed by now, maybe even available as a treatment for those people suffering.

and

Scancell as a company would be solvent and have the financial resources to fund further trials on the remaining platform, rather than continuously raising money at lower and lower prices... You're BONKERS

[torquayfan] 04/2/2019 10:55

P7 - selling SCIB1 at Phase 1 was the 'plan'. Plans are brought to fruition sometimes and sometimes not. Many a slip 'twixt cup and lip ! In good faith . . .

NXC is being open and helpful and no doubt, he shared your disappointment at the time.

[inanaco] 04/2/2019 10:54

Gazza

So you really are a Space Cadet

[gazza] 04/2/2019 10:49

I've just discovered a trillion dollars worth of gold on Pluto. I just need 20 billion to go and get it. No takers? You're kidding, do you not understand the market value of gold?

[tosh123] 04/2/2019 10:41

P7,
I think that DE is suggesting that as well as the lack of sufficient data, the fact that no one had the status to be able to get in front of the " right people " was also instrumental in the failure to get a deal.
Coming from a city background, i appreciate how important it is to " know " the right people, if one can receive some form of personal validation, it does make a difference, i do however agree with your observation about other companies achieving deals with less proof of concept than us, and as i've always said, i think the commercial aspect of scancell has been continually lacking ( something that DE eludes to ).
On the funding front, im still hoping that money will be derived via some form of philanthropy.
In this instance, the actual science will not be challenged in the same manner as an industry insider would, its more about the chances of success and doing the right thing.
We live in hope.

[inanaco] 04/2/2019 10:35

NXC

With what we know now, and the explosion in the sector, i am glad you did not sell.

the Market still does not get that we are about to trial with the Current "standard of Care"

It also does not appreciate just how big the market will be for moditope

the continued development and further discovery inc Homocitrulline has just not been priced in at all

[nxc] 04/2/2019 10:27

Panama7 - there was a genuinely held view held by the Board and others we engaged with that we could sell SCIB1 - there was no duping or misleading in that regard. When you enter into such a process you know there is no guarantee the asset/company will be sold. I laid out yesterday the efforts the Company went to in order to secure a positive outcome and I explained the reasons for that. Could we have done anything differently ? Would a different adviser made a difference? I think the team worked really hard to secure a positive outcome but it was not to be. Why other pre-clinical deals get done will be down to circumstance and context and I cannot comment on those deals as I have no knowledge. I understand your anger with past and present boards but our ambition to sell the asset/company was a reasonable ambition and one pursued in good faith at the time.

[panama7] 04/2/2019 10:09

Knowing what we all know now the Company should never ever have told Investors it was going to be sold after the Phase1 results. All of us Investors were totally duped into believing the company could be sold when it was never a reality. NXC has stated it was due to lack of data but how come other assets have been sold at the preclinical stage for many multiples of our Market Cap. Why has no one done a preclinical deal on the "serendipitous discovery of Moditope". After all Lindy has never seen anything like it.

[tosh123] 04/2/2019 09:54

ONW,
lets just hope that the " perpetrators ", having been exposed, are now less vocal and a lot more humble ( however, i doubt that will happen due to the ego involved ).
Its just refreshing to be able to back up what a lot of us have been saying for years, by words from someone who actually knows what they're talking about.

The cut and post rubbish is now shown as being exactly what it is, " cut and paste ".


IMHO, if there is a rabbit, it may well not be a bio rabbit. It may be funding from a totally diverse source.
Lets just wait and see, but i cant see that another cash raise will achieve anything like the cash required, even if it was fully supported. There has to be something else sitting in the wings.
Im still about 50/50 that we will have some kind of sale... eg ;- we can make all the flags we want, but if we cant afford to keep them........

[nxc] 04/2/2019 09:47

Bermudashorts - my knowledge of health economics is limited to the work undertaken with DxEconomix which is focused on diagnostics and the studies undertaken do not extend to the purity of your approach. I think the approach you have suggested is the gold standard and perhaps the only way - I was looking for something more quick and dirty. I would welcome other inputs as to the art of the possible given the limited resources.

[oldnotwise] 04/2/2019 09:36

Tosh,
Yes, In fairness Scancell had mentioned that getting through the Pharma doors was a good part of the Funding issue, and that was some time ago. This was always glossed over by some posters... BUT given what we know now, it's a shame that uniformed "information" was not only put out , but actively allowed to flourish, which probably says more about the quality of the knowledge (or lack of it) of the perpetrators. It does of course raise the question as to whether the perpetrators were actually novice uninformed people, or in a more sinister scenario whether they knew what they were doing.
If the latter was/is the case then that's pretty serious.
I say this as a purely personal viewpoint, and is my own opinion.
In the meantime, let's hope for the data we expect, but it seems it's not going to begranted immediately....
AIMO
ATB